Submitted:
04 July 2025
Posted:
07 July 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Results
Evaluation after 24 hours
3. Discussion
- Shock Index: prognostic value and molecular mechanisms
- Lactate levels: prognostic value and molecular mechanisms
- Hemodynamic incoherence during sepsis: does it have a role in the ED?
4. Materials and Methods
- Statistical Analysis
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
Abbreviations
| SSI | Systolic Shock Index |
| DSI | Diastolic Shock Index |
| COPD | Chronic Obstructive Pulmonary Disease; |
| CKD | Chronic Kidney Disease; |
| WBC | white blood cell; |
| PLT | platelets; |
| PCT | procalcitonin |
| INR | International Normalized Ratio |
| MAP | Mean Arterial Pressure |
| SP | Systolic Blood Pressure |
| HR | heart rate |
| RR | respiratory rate |
| P/F | po2/fi02 |
| GCS | Glasgow coma scale; |
References
- Update on Sepsis and Septic Shock: Mortality and Clinical Management. Journal of Clinical Medicine, 12(8), 3188.
- Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181–247.
- Vellinga NAR, Boerma EC, Koopmans M, Donati A, Dubin A, Shapiro NI, et al. International Study on Microcirculatory Shock Occurrence in Acutely Ill Patients*: Crit Care Med. 2015 Jan;43(1):48–56.
- Yang H, Du L, Zhang Z. Potential biomarkers in septic shock besides lactate. Exp Biol Med. 2020 Jun;245(12):1066–72. [CrossRef]
- Jeppesen JB, Mortensen C, Bendtsen F, Møller S. Lactate metabolism in chronic liver disease. Scand J Clin Lab Invest. 2013 Jun;73(4):293–9. [CrossRef]
- Kushimoto S, Akaishi S, Sato T, Nomura R, Fujita M, Kudo D, et al. Lactate, a useful marker for disease mortality and severity but an unreliable marker of tissue hypoxia/hypoperfusion in critically ill patients. Acute Med Surg. 2016 Oct;3(4):293–7. [CrossRef]
- Yajnik V, Maarouf R. Sepsis and the microcirculation: the impact on outcomes. Curr Opin Anaesthesiol. 2022 Apr;35(2):230–5. [CrossRef]
- De Backer D, Donadello K, Sakr Y, Ospina-Tascon G, Salgado D, Scolletta S, et al. Microcirculatory Alterations in Patients With Severe Sepsis: Impact of Time of Assessment and Relationship With Outcome*. Crit Care Med. 2013 Mar;41(3):791–9.
- Chertoff J, Chisum M, Garcia B, Lascano J. Lactate kinetics in sepsis and septic shock: a review of the literature and rationale for further research. J Intensive Care. 2015 Dec;3(1):39. [CrossRef]
- Diaztagle Fernández JJ, Castañeda-González JP, Trujillo Zambrano JI, Duarte Martínez FE, Saavedra Ortiz MÁ. Assessment of the shock index in septic shock: A systematic review. Med Intensiva Engl Ed. 2024 Nov;48(11):e10–9.
- De Backer D, Cecconi M, Chew MS, Hajjar L, Monnet X, Ospina-Tascón GA, et al. A plea for personalization of the hemodynamic management of septic shock. Crit Care. 2022 Dec 1;26(1):372. [CrossRef]
- Sahu N, Yee S, Das M, Trinh S, Amoruso R, Connolly M, et al. Shock Index as a Marker for Mortality Rates in Those Admitted to the Medical Intensive Care Unit from the Emergency Department. Cureus [Internet]. 2020 Apr 30 [cited 2025 May 2]; Available from: https://www.cureus.com/articles/26238-shock-index-as-a-marker-for-mortality-rates-in-those-admitted-to-the-medical-intensive-care-unit-from-the-emergency-department.
- Koch E, Lovett S, Nghiem T, Riggs R, Rech MA. Shock index in the emergency department: utility and limitations. Open Access Emerg Med. 2019 Aug;Volume 11:179–99. [CrossRef]
- Collin S, Sennoun N, Dron AG, De La Bourdonnaye M, Montemont C, Asfar P, et al. Vascular ATP-sensitive potassium channels are over-expressed and partially regulated by nitric oxide in experimental septic shock. Intensive Care Med. 2011 May;37(5):861–9. [CrossRef]
- Joffre J, Hellman J, Ince C, Ait-Oufella H. Endothelial Responses in Sepsis. Am J Respir Crit Care Med. 2020 Aug 1;202(3):361–70.
- Lambden S, Creagh-Brown BC, Hunt J, Summers C, Forni LG. Definitions and pathophysiology of vasoplegic shock. Crit Care. 2018 Dec;22(1):174. [CrossRef]
- Levy B, Fritz C, Tahon E, Jacquot A, Auchet T, Kimmoun A. Vasoplegia treatments: the past, the present, and the future. Crit Care. 2018 Dec;22(1):52. [CrossRef]
- Bakker J. Lactate levels and hemodynamic coherence in acute circulatory failure. Best Pract Res Clin Anaesthesiol. 2016 Dec;30(4):523–30. [CrossRef]
- Holmbom M, Andersson M, Berg S, Eklund D, Sobczynski P, Wilhelms D, et al. Prehospital delay is an important risk factor for mortality in community-acquired bloodstream infection (CA-BSI): a matched case–control study. BMJ Open. 2021 Nov;11(11):e052582. [CrossRef]
- Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017 Jul;39(5):517–28. [CrossRef]
- The ProCESS Investigators. A Randomized Trial of Protocol-Based Care for Early Septic Shock. N Engl J Med. 2014 May;370(18):1683–93.


| All (n=1392) |
G1 (n=236) |
G2 (n=574) |
G3 (n=582) |
|
| Male (%) | 779 (56%) | 125 (53%) | 327 (57%) | 327 (56%) |
| Age (Years) | 75±14 | 77 ±13°^ | 74±15 | 74±13 |
| Hypertension (%) | 803 (58%) | 151(35%) | 324 (43%) | 328 (43%) |
| Cancer (%) | 356 (26%) | 46 (20%) ° | 136 (24%) § | 174 (30%) |
| COPD (%) | 314 (23%) | 65 (28%) | 131 (23%) | 119 (20%) |
| IRC (%) | 298 (21%) | 60 (25%) ^ | 141 (25%) § | 97(17%) |
| Diabetes (%) | 282 (27%) | 52 (31%) | 116 (27%) | 115 (20%) |
| Sepsis source | ||||
| Pulmonary | 682 (9%) | 120 (51%) | 281 (49%) | 281 (48%) |
| Urinary | 394 (28%) | 67 (29%) | 176 (31%) | 151 (26%) |
| Other | 311 (22%) | 47 (20%) | 117 (20%) | 147 (25%) |
| Laboratory data | ||||
| WBC (Ux109/L) | 14,6±11 | 13±7°^ | 15±13 | 15±13 |
| PLT (Ux106/L) | 196±118 | 203±193 | 200±114 | 188±121 |
| Bilirubin (mg/dl) | 1,1±1,6 | 0,7±0,8^ | 1,2±2 | 1,3±1,5 |
| Creatinine (mg/dl) | 2±1,7 | 2±1,7 | 2,1±1,8 | 2±1,5 |
| INR | 1.6±1,3 | 1,5±0,8^ | 1,6±1,1 | ±1,7±1,6 |
| PCT (ng/ml) | 38±74 | 23±47^ | 30±66 § | 50±85 |
| 7-days-mortality (%) | 269 (19%) | 32 (14%) ^ | 91 (16%) § | 146 (25%) |
| 28-days-mortality (%) | 426 (31%) | 62 (26%) ^ | 156 (27%) § | 208 (35%) |
| T0 | T24 | |||||||
|
All patients (n=1392) |
G1 (n=236) |
G2 (n=574) |
G3 (n=582) |
All patients (n=1375) |
J1 (n=424) |
J2 (n=683) |
J3 (n=268) |
|
| MAP (mmHg) | 77±18 | 91 ±17 °^ | 76±16 § | 72 ±16 | 78±14 | 83±14 °^ | 75±12 § | 72±14 |
| SBP (mmHg) | 106±29 | 135±26^° | 105±26 § | 95±24 | 110±25 | 130±20 ^° | 104±22 § | 97±24 |
| HR (bpm) | 98±23 | 76±14°^ | 97±21§ | 108±21 | 90±19 | 75±12^° | 95±18 § | 103±17 |
| RR (rpm) | 24±8 | 22±10^ | 23±7 § | 25±8 | 22±6 | 20±5°^ | 22±6 § | 24±7 |
| BT (C°) | 37±1,5 | 36,7±1,5 ° | 37,7±1,3 § | 37,2±1,4 | 37,5±1,4 | 36.5±2 | 36.6±1 | 36.6±1 |
| P/F | 277±16 | 291±107 | 280±116 | 269±118 | 263±117 | 277±113^ | 268±117 § | 230±116 |
| GCS | 15[14-15] | 15 [15-15] ^ | 15 [15-15] § | 15 [14-15] | 15 [15-15] | 15 [15-15] ^ | 15 [15-15] § | 15 [14-15] |
| SSI | 1±0,4 | 0,5±0,1^° | 0,1±0,3 § | 1,2±0,4 | 0,9±0,3 | 0.6±0.1°^ | 0,9±0,3 § | 1,1±0,3 |
| Lactate (mEq/l) | 2,8 ±2,6 | 1,1±0,5 ^° | 1,7±1,4 § | 4,6±3.0 | 1,8±1,8 | 1±0,4^° | 1,4 ±1,3 § | 4±2,6 |
| SOFA score | 5[3-7] | 4 [2-6] °^ | 5 [3-7] § | 5,5[4-8] | 5 [3-7] | 4 [3-6]°^ | 5 [3-7] § | 7[4-9] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).